The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Acerycal 5mg/5mg tablets

5mg/5 milligram(s) Tablet

PCO Manufacturing Ltd.PPA0465/283/001

Main Information

Trade NameAcerycal 5mg/5mg tablets
Active SubstancesPerindopril arginine
Amlodipine besylate
Strength5mg/5 milligram(s)
Dosage FormTablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/283/001

Group Information

ATC CodeC09BB ACE inhibitors and calcium channel blockers
C09BB04 perindopril and amlodipine

Status

Authorised/WithdrawnAuthorised
Licence Issued20/04/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0041-012-002
Interchangeable List DocumentPDF of Interchangeable List
« Back